Castleman Disease

This is a rare condition that affects the lymph nodes, which are part of your immune system. It causes the lymph nodes to become enlarged and sometimes painful. It's usually not serious, but it can sometimes be linked to other health problems.

Condition

What people with Castleman Disease report

Every report comes from a Lived member, sent anonymously.

Have you had Lymph Node Removal for Castleman Disease?

NameHow it went

About Castleman Disease

What It Is

Castleman disease is a group of rare disorders in which lymph nodes enlarge and take on a distinctive appearance under the microscope. Lymph nodes are small immune organs found throughout the body. In Castleman disease, immune cells in the affected nodes overgrow, and in some forms they release large amounts of inflammatory signals that affect the whole body. It is not a cancer, although some forms are linked to a higher risk of lymphoma. The name covers conditions that behave very differently, so the type matters more than the label. Unicentric Castleman disease involves a single lymph node or one group of nodes. It is often found by chance on a scan, and when it does cause symptoms, they usually come from the enlarged node pressing on nearby structures. Multicentric Castleman disease involves several groups of nodes and usually causes body-wide illness: fevers, night sweats, weight loss, fatigue, fluid buildup and an enlarged liver or spleen. In severe cases it can affect blood counts, the kidneys and other organs.

Causes & Risk Factors

Doctors divide multicentric Castleman disease by what drives it. One type is caused by human herpesvirus 8 (HHV-8), a virus that is also responsible for Kaposi sarcoma. It mostly affects people whose immune systems are weakened, especially people living with HIV. Another type occurs alongside POEMS syndrome, a disorder of abnormal antibody-producing plasma cells that also damages nerves. A third type, idiopathic multicentric Castleman disease (iMCD), has no known cause. In iMCD, an inflammatory signaling protein called interleukin-6 (IL-6) plays a major role in many people, which is why treatment often targets it. The cause of unicentric disease is also not well understood. Castleman disease is not known to result from anything a person did, and the idiopathic forms are not contagious. Idiopathic multicentric disease is diagnosed most often in middle-aged adults, but it can occur at any age, and it appears to be more common among Polynesian people.

How It's Diagnosed

Because enlarged lymph nodes and inflammatory symptoms have many causes, diagnosing Castleman disease takes a lymph node biopsy and a careful search for other explanations. A surgeon usually removes a whole node, or a substantial piece of one, so a pathologist can see its structure. A fine needle sample removes only scattered cells and is not enough to make the diagnosis. CT or PET-CT scans show whether one region or several are involved, which separates unicentric from multicentric disease and also looks for fluid around the lungs or in the abdomen and an enlarged liver or spleen. Blood and urine tests check blood counts, kidney and liver function, albumin, antibody levels and inflammation markers such as C-reactive protein (CRP). Testing for HHV-8 and HIV is essential, because virus-driven disease needs different treatment. Doctors also look for lymphoma, infections and autoimmune diseases such as lupus that can look similar, and a bone marrow biopsy is often part of that search. Because these findings overlap with so many conditions, the diagnosis is often confirmed by a hematologist (a blood disorder specialist) working with an experienced pathologist.

Treatment Options

Treatment depends on the type. For unicentric disease, surgery to remove the affected node or nodes is the preferred treatment and is often curative when the whole area can be removed. When surgery is not possible, a node that causes no symptoms may simply be watched. Medicines, radiation therapy or a procedure that blocks the node's blood supply can shrink a node that is pressing on important structures, sometimes making later surgery possible. For idiopathic multicentric disease, the first treatment is usually siltuximab (Sylvant), an antibody given as an IV infusion every three weeks that blocks IL-6. It is the only medicine approved in the US for this condition. In its main trial, about a third of people had a lasting improvement in both their nodes and their symptoms, and many others had partial or symptom improvement. Guidelines recommend that people who respond stay on it long term. Steroids are often added for a short time while siltuximab takes effect. When IL-6 blockade does not work well enough, the next options include rituximab (Rituxan), an antibody that removes the B cells involved in the disease, immune-suppressing medicines and, for severe disease, chemotherapy. For HHV-8-associated disease, rituximab is the usual first treatment, sometimes combined with chemotherapy, and has greatly improved survival. People with HIV also start or continue HIV medicines. Rituximab can make Kaposi sarcoma worse, so care teams watch for it and may add treatment for it.

What to Expect

The outlook varies widely by type. After complete removal, unicentric disease rarely returns, and the long-term outlook is excellent for most people. Follow-up usually includes yearly scans and blood tests, often for about five years. Inflammatory symptoms that some people had before surgery usually improve once the node is removed, although a few people continue to have symptoms. Multicentric disease is usually a long-term condition. Some people have mild symptoms that are well controlled on treatment, while others, particularly with the rapid-onset form called TAFRO, become seriously ill quickly and need hospital care. Treatment often controls the disease well but not in everyone, and finding the right medicine can take time. Living with iMCD often means regular infusions, blood tests to track inflammation and organ function, and periodic scans. People with HHV-8-associated disease also need ongoing HIV care when relevant and monitoring for Kaposi sarcoma and lymphoma. Because the condition is rare, care at or in consultation with a center experienced in Castleman disease can help, and patient networks such as the Castleman Disease Collaborative Network connect people with specialists and research.

When to Seek Help

See a clinician if you notice a lymph node that stays enlarged for more than a few weeks, or if you have ongoing fevers, night sweats, unexplained weight loss or persistent fatigue. If you have Castleman disease, tell your care team about returning symptoms, new swelling or treatment side effects. If you take siltuximab or another IL-6 blocking medicine, contact your care team promptly for any sign of infection, such as a cough, painful urination or feeling generally unwell. These medicines can prevent a fever, so infections may not announce themselves in the usual way. Get same-day medical care for shortness of breath, rapidly worsening swelling of the legs, body or abdomen, passing much less urine, or high fevers with marked weakness, especially with multicentric disease. These can signal a serious flare that needs urgent treatment.

Questions to Ask Your Doctor

  1. 1.Which type of Castleman disease do I have, and how was that determined?
  2. 2.Have I been tested for HHV-8 and HIV, and how do those results change my treatment?
  3. 3.If my disease is unicentric, can it be removed completely, and what follow-up will I need afterward?
  4. 4.How will we know whether my treatment is working, and what are the next options if it is not?
  5. 5.Should my care involve a center or specialist with experience in Castleman disease?

Last reviewed • Oct 2026

Educational content, not medical advice.